Luminate Medical
Oncology side effects prevention at home
Galway, Ireland
Luminate Medical develops wearable medical devices and technology-led services to mitigate chemotherapy-induced side effects like hair loss and peripheral neuropathy.
How We Help
Problem Statement
To mitigate painful chemotherapy-induced side effects, such as hair loss and peripheral neuropathy, and to enable the administration of low-risk anti-cancer drugs at home, thereby improving the quality of life for cancer patients and reducing the burden on clinics.
Core Technology
Wearable Devices
Key Differentiators
Enables at-home administration of low-risk anti-cancer drugs; Focus on mitigating chemotherapy side effects like hair loss and peripheral neuropathy
Clinical Focus
Oncology
Company Info
- Business Model
- Hybrid
- Total Funding
- 50,000,000
- Website
- luminate.medical
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Lily prevents chemotherapy-induced hair loss across taxane/platinum regimens; Lilac shows >90% reduction in neuropathy symptoms; PREVAIL and IMPACT trials ongoing; FDA approval expected 2027.
MedStartr Index Score
?What do you think of Luminate Medical?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.